Synergy Bioscience

Synergy Bioscience is a private, revenue-generating services company founded in 2016, operating as a Contract Research, Development, Manufacturing, Testing, and Consulting Organization (CRDMO). It offers an integrated suite of development and testing services to pharmaceutical and biotech clients, with core capabilities in analytical method development, extractables/leachables, biocompatibility, and regulatory consulting for FDA submissions. The company positions itself as a scientific and strategic partner to help clients navigate complex development pathways and quality standards efficiently.

Integrated contract services platform for pharmaceutical/device development, including analytical chemistry, microbiology, extractables/leachables, biocompatibility testing, formulation, and regulatory consulting. Specialized in development and pilot manufacturing of Antibody-Drug Conjugates (ADCs) and Antibody-Oligonucleotide Conjugates (AOCs).

Synergy competes with large global CROs/CDMOs (e.g., Charles River, LabCorp, Catalent), specialized analytical testing labs, and regulatory consulting firms. Its differentiation lies in its integrated service model, niche expertise in conjugate development, and combined laboratory/consulting approach for regulatory submissions.